For Ozempic (used off-label for weight loss), 1.0 mg is the standard maintenance dose
*In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly via subcutaneous injection, the FDA-approved formulation later marketed under the brand name Wegovy for chronic weight management in adults with obesity or overweight and at least one weight-related condition
While there is no clinical diagnosis for this exactly, it is a side effect sometimes noted by those who are using semaglutide (Ozempic or Wegovy) injections to lose weight
Neither decision removes the need to inspect the exact label
Additionally, epitalon restores pineal melatonin secretion in aging models, potentially addressing the circadian rhythm disruption that accompanies biological aging
Molecular mechanisms underlying vascular remodeling in hypertension